Table 1.

Relative expression of PANDAR, p53-Ser15, and PUMA in patients with newly diagnosed and recurrent ovarian cancer

No	Age (years)	Classification	FIGO stage	Differentiation	Platinum sensitive (N/R)	p53 mutation	PANDAR Exp. (N/R)	p53-Ser15 Exp. (N/R)	PUMA Exp. (N/R)
1	50	OCCC	IIB	N/A	Yes/ No	No	Low/ high	High/ low	High/ low
2	51	ENOC	IIIC	Poor	Yes/ No	No	Low/ high	High/ low	High/ low
3	49	ENOC	IIIA	Poor	Yes/ No	No	Low/ high	High/ low	High/ low
4	53	HGSOC	IIC	Poor	Yes/ No	No	Low/ high	High/ low	High/ low
5	80	HGSOC	IIIB	Poor	No/ No	Yes	Low/ low	Low/ low	Low/ low
6	62	HGSOC	IIIC	Moderate	No/ No	Yes	Low/ low	Low/ low	Low/ low
7	56	HGSOC	IIIC	Poor	No/ No	Yes	Low/ low	Low/ low	Low/ low

Low, below the median of the intergrated optical density. High, above the median of the intergrated optical density

HGSOC high-grade serous ovarian cancer, OCCC ovarian ovarian clear cell carcinomas, ENOC endometrioid ovarian cancer, Exp expression, N newly diagnosed, R recurrence